Anika and Zimmer terminate Orthovisc deal

ANIK and Zimmer, a subsidiary of Bristol-Myers (BMY), terminated their distribution deal for ANIK's Orthovisc hyaluronic acid treatment for ostoarthritis of the knee. Zimmer had been the exclusive dis...